Ocugen, Inc. (OCGN)
NASDAQ·Healthcare·Biotechnology
$1.68
-1.47%
Mkt Cap $544.31M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 4, 2026 | $1.07M | -$193.00K | -117.95% | -$0.06 | -$0.06 | +0.00% | — | — |
| Q4 2025 Nov 5, 2025 | $440.00K | $1.75M | +298.18% | -$0.06 | -$0.07 | -21.74% | — | — |
| Q3 2025 Aug 1, 2025 | $300.00K | $1.37M | +357.67% | -$0.06 | -$0.05 | +16.67% | — | — |
| Q2 2025 May 9, 2025 | — | $1.48M | — | -$0.06 | -$0.05 | +16.67% | — | — |
| Q1 2025 Mar 5, 2025 | $400.00K | $764.00K | +91.00% | -$0.05 | -$0.05 | +0.00% | — | — |
| Q4 2024 Nov 14, 2024 | $300.00K | $1.14M | +278.67% | -$0.05 | -$0.05 | +0.00% | — | — |
| Q3 2024 Aug 8, 2024 | — | $1.14M | — | -$0.06 | -$0.04 | +33.33% | — | — |
| Q2 2024 Apr 16, 2024 | — | $1.01M | — | -$0.06 | -$0.04 | +33.33% | — | — |
| Q1 2024 Mar 26, 2024 | — | $6.04M | — | -$0.06 | -$0.03 | +50.00% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.08 | -$0.06 | +25.00% | — | — |
| Q3 2023 Aug 21, 2023 | — | — | — | -$0.08 | -$0.10 | -25.00% | — | — |
| Q2 2023 May 5, 2023 | — | $443.00K | — | -$0.11 | -$0.07 | +36.36% | — | — |
| Q1 2023 Feb 28, 2023 | $2.17M | — | — | -$0.11 | -$0.10 | +9.09% | — | — |
| Q4 2022 Nov 8, 2022 | — | — | — | -$0.10 | -$0.10 | +0.00% | — | — |
| Q3 2022 Aug 5, 2022 | — | — | — | -$0.08 | -$0.09 | -12.50% | — | — |
| Q2 2022 May 6, 2022 | $13.87M | — | — | $0.05 | -$0.09 | -280.00% | — | — |
| Q1 2022 Feb 25, 2022 | $13.87M | — | — | -$0.07 | -$0.07 | +0.00% | — | — |
| Q4 2021 Nov 9, 2021 | — | — | — | -$0.04 | -$0.05 | -25.00% | — | — |
| Q3 2021 Aug 6, 2021 | — | — | — | -$0.03 | -$0.13 | -333.33% | — | — |
| Q2 2021 May 7, 2021 | $78.10M | — | — | $0.50 | -$0.04 | -108.00% | — | — |